Identification of microRNAs associated with abdominal aortic aneurysms and peripheral arterial disease

British Journal of Surgery

Volumn 102, Issue 7, 2015, Pages 755-766

  Stather, P W ^a   Sylvius, N ^a   Sidloff, D A ^a   Dattani, N ^a   Verissimo, A ^a   Wild, J B ^a   Butt, H Z ^a   Choke, E ^a   Sayers, R D ^a   Bown, M J ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GENETIC MARKER; MICRORNA;

ABDOMINAL AORTA ANEURYSM; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POLYMERASE CHAIN REACTION; REPRODUCIBILITY;

AORTIC ANEURYSM, ABDOMINAL; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS;

EID: 84929027152     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.9802     Document Type: Article

References (42)

1. Kuivaniemi H, Shibamura H, Arthur C, Berguer R, Cole CW, Juvonen T, et al,. Familial abdominal aortic aneurysms: collection of 233 multiplex families. J Vasc Surg 2003; 37: 340-345.
2. Sakalihasan N, Limet R, Defawe OD,. Abdominal aortic aneurysm. Lancet 2005; 365: 1577-1589.
3. Wahlgren CM, Larsson E, Magnusson PK, Hultgren R, Swedenborg J,. Genetic and environmental contributions to abdominal aortic aneurysm development in a twin population. J Vasc Surg 2010; 51: 3-7.
4. Sandiford P, Mosquera D, Bramley D,. Ethnic inequalities in incidence, survival and mortality from abdominal aortic aneurysm in New Zealand. J Epidemiol Community Health 2012; 66: 1097-1103.
5. Rossaak JI, Sporle A, Birks CL, van Rij AM,. Abdominal aortic aneurysms in the New Zealand Maori population. Br J Surg 2003; 90: 1361-1366.
6. Sweeting MJ, Thompson SG, Brown LC, Powell JT; RESCAN collaborators. Meta-analysis of individual patient data to examine factors affecting growth and rupture of small abdominal aortic aneurysms. Br J Surg 2012; 99: 655-665.
7. Giugliano G, Laurenzano E, Rengo C, De Rosa G, Brevetti L, Sannino A, et al,. Abdominal aortic aneurysm in patients affected by intermittent claudication: prevalence and clinical predictors. BMC Surg 2012; 12 (Suppl 1): S17.
8. Cornuz J, Sidoti Pinto C, Tevaearai H, Egger M,. Risk factors for asymptomatic abdominal aortic aneurysm: systematic review and meta-analysis of population-based screening studies. Eur J Public Health 2004; 14: 343-349.
9. Golledge J, Norman PE,. Atherosclerosis and abdominal aortic aneurysm: cause, response, or common risk factors? Arterioscler Thromb Vasc Biol 2010; 30: 1075-1077.
10. Gretarsdottir S, Baas AF, Thorleifsson G, Holm H, den Heijer M, de Vries JP, et al,. Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm. Nat Genet 2010; 42: 692-697.
11. Jones GT, Bown MJ, Gretarsdottir S, Romaine SP, Helgadottir A, Yu G, et al,. A sequence variant associated with sortilin-1 (SORT1) on 1p13.3 is independently associated with abdominal aortic aneurysm. Hum Mol Genet 2013; 22: 2941-2947.
12. Bown MJ, Jones GT, Harrison SC, Wright BJ, Bumpstead S, Baas AF, et al,. Abdominal aortic aneurysm is associated with a variant in low-density lipoprotein receptor-related protein 1. Am J Hum Genet 2011; 89: 619-627.
13. Bradley DT, Hughes AE, Badger SA, Jones GT, Harrison SC, Wright BJ, et al,. A variant in LDLR is associated with abdominal aortic aneurysm. Circ Cardiovasc Genet 2013; 6: 498-504.
14. Thompson AR, Drenos F, Hafez H, Humphries SE,. Candidate gene association studies in abdominal aortic aneurysm disease: a review and meta-analysis. Eur J Vasc Endovasc Surg 2008; 35: 19-30.
15. Sidloff DA, Stather PW, Choke E, Bown MJ, Sayers RD,. A systematic review and meta-analysis of the association between markers of hemostasis and abdominal aortic aneurysm presence and size. J Vasc Surg 2014; 59: 528-535.e4.
16. Stather PW, Sidloff DA, Dattani N, Gokani VJ, Choke E, Sayers RD, et al,. Meta-analysis and meta-regression analysis of biomarkers for abdominal aortic aneurysm. Br J Surg 2014; 101: 1358-1372.
17. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T,. Identification of tissue-specific microRNAs from mouse. Curr Biol 2002; 12: 735-739.
18. Liu CG, Calin GA, Meloon B, Gamliel N, Sevignani C, Ferracin M, et al,. An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci U S A 2004; 101: 9740-9744.
19. Tang Y, Liu D, Zhang L, Ingvarsson S, Chen H,. Quantitative analysis of miRNA expression in seven human foetal and adult organs. PLoS One 2011; 6: e28730.
20. Jopling CL, Norman KL, Sarnow P,. Positive and negative modulation of viral and cellular mRNAs by liver-specific microRNA miR-122. Cold Spring Harb Symp Quant Biol 2006; 71: 369-376.
21. Bostjancic E, Zidar N, Stajer D, Glavac D,. MicroRNAs miR-1, miR-133a, miR-133b and miR-208 are dysregulated in human myocardial infarction. Cardiology 2010; 115: 163-169.
22. Pahl MC, Derr K, Gäbel G, Hinterseher I, Elmore JR, Schworer CM, et al,. MicroRNA expression signature in human abdominal aortic aneurysms. BMC Med Genomics 2012; 5: 25.
23. Kin K, Miyagawa S, Fukushima S, Shirakawa Y, Torikai K, Shimamura K, et al,. Tissue- and plasma-specific microRNA signatures for atherosclerotic abdominal aortic aneurysm. J Am Heart Assoc 2012; 1: e000745.
24. Maegdefessel L, Dalman RL, Tsao PS,. Pathogenesis of abdominal aortic aneurysms: microRNAs, proteases, genetic associations. Annu Rev Med 2014; 65: 49-62.
25. Stather P, Wild J, Sylvius N, Choke E, Sayers R, Bown M,. MicroRNAs associated with the pathways involved in the pathogenesis of abdominal aortic aneurysms. Artery Research 2012; 7: 28-35.
26. Adam M, Raaz U, Spin JM, Tsao PS,. MicroRNAs in abdominal aortic aneurysm. Curr Vasc Pharmacol 2013; [Epub ahead of print].
27. Biros E, Moran CS, Wang Y, Walker PJ, Cardinal J, Golledge J,. MicroRNA profiling in patients with abdominal aortic aneurysms: the significance of miR-155. Clin Sci (Lond) 2014; 126: 795-803.
28. Zampetaki A, Attia R, Mayr U, Gomes RS, Phinikaridou A, Yin X, et al,. Role of miR-195 in aortic aneurysmal disease. Circ Res 2014; 115: 857-866.
29. Dweep H, Sticht C, Pandey P, Gretz N,. miRWalk-database: prediction of possible miRNA binding sites by 'walking' the genes of three genomes. J Biomed Inform 2011; 44: 839-847.
30. Boon RA, Seeger T, Heydt S, Fischer A, Hergenreider E, Horrevoets AJ, et al,. MicroRNA-29 in aortic dilation: implications for aneurysm formation. Circ Res 2011; 109: 1115-1119.
31. Maegdefessel L, Azuma J, Toh R, Merk DR, Deng A, Chin JT, et al,. Inhibition of microRNA-29b reduces murine abdominal aortic aneurysm development. J Clin Invest 2012; 122: 497-506.
32. Lee ST, Chu K, Im WS, Yoon HJ, Im JY, Park JE, et al,. Altered microRNA regulation in Huntington's disease models. Exp Neurol 2011; 227: 172-179.
33. Liu X, Cheng Y, Chen X, Yang J, Xu L, Zhang C,. MicroRNA-31 regulated by the extracellular regulated kinase is involved in vascular smooth muscle cell growth via large tumor suppressor homolog 2. J Biol Chem 2011; 286: 42 371-42 380.
34. Cheng Y, Liu X, Yang J, Lin Y, Xu DZ, Lu Q, et al,. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res 2009; 105: 158-166.
35. Damrauer SM, Csizmadia E, Studer P, Bhasin M, Da Silva CG, Peterson CR, et al,. Partial loss of A20 (Tnfaip3) promotes resistance to abdominal aortic aneurysms. ATVB 2010; 30: e317.
36. Davis BN, Hilyard AC, Nguyen PH, Lagna G, Hata A,. Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype. J Biol Chem 2009; 284: 3728-3738.
37. Liu G, Huang Y, Lu X, Lu M, Huang X, Li W, et al,. Identification and characteristics of microRNAs with altered expression patterns in a rat model of abdominal aortic aneurysms. Tohoku J Exp Med 2010; 222: 187-193.
38. Stather PW, Sylvius N, Wild JB, Choke E, Sayers RD, Bown MJ,. Differential microRNA expression profiles in peripheral arterial disease. Circ Cardiovasc Genet 2013; 6: 490-497.
39. Leeper NJ, Raiesdana A, Kojima Y, Chun HJ, Azuma J, Maegdefessel L, et al,. MicroRNA-26a is a novel regulator of vascular smooth muscle cell function. J Cell Physiol 2011; 226: 1035-1043.
40. Maegdefessel L, Azuma J, Toh R, Merk DR, Deng A, Chin JT, et al,. Inhibition of microRNA-29b reduces murine abdominal aortic aneurysm development. J Clin Invest 2012; 122: 497-506.
41. Maegdefessel L, Azuma J, Toh R, Deng A, Merk DR, Raiesdana A, et al,. MicroRNA-21 blocks abdominal aortic aneurysm development and nicotine-augmented expansion. Sci Transl Med 2012; 4: 122ra22.
42. Maegdefessel L, Raaz U, Toh R, Deng A, Chernogubova E, Eriksson P, et al,. MicroRNA-24 regulates inflammation and calcification during abdominal aortic aneurysm development through targeting Ykl-40. Circ Suppl 2012; 126: A14221.